HomeVTYX • NASDAQ
add
Ventyx Biosciences Inc
Previous close
$1.73
Day range
$1.71 - $1.92
Year range
$1.67 - $11.48
Market cap
130.81M USD
Avg Volume
1.03M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 38.55M | -33.47% |
Net income | -35.25M | 34.76% |
Net profit margin | — | — |
Earnings per share | -0.50 | 45.65% |
EBITDA | -38.49M | 33.55% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 274.82M | -8.64% |
Total assets | 301.10M | -6.40% |
Total liabilities | 22.33M | -41.34% |
Total equity | 278.77M | — |
Shares outstanding | 70.71M | — |
Price to book | 0.44 | — |
Return on assets | -31.58% | — |
Return on capital | -33.13% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -35.25M | 34.76% |
Cash from operations | -35.46M | -2.30% |
Cash from investing | 29.25M | -24.80% |
Cash from financing | 26.86M | 1,553.05% |
Net change in cash | 20.84M | 255.15% |
Free cash flow | -21.27M | -44.82% |
About
Founded
2018
Website
Employees
75
